Entero Therapeutics (ENTO) announced that it has secured a $2M revolving loan agreement and subsequently appointed three new members to its ...

As a condition for the loan, Entero replaced three of five members of its Board of Directors with three new directors designated by the lender. These appointments follow the resignations of James ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...